Related Experiment Video
Updated: Apr 23, 2026

A High-throughput Assay for the Prediction of Chemical Toxicity by Automated Phenotypic Profiling of Caenorhabditis elegans
Published on: March 14, 2019
Quantitative high-throughput profiling of environmental chemicals and drugs that modulate farnesoid X receptor
Chia-Wen Hsu1, Jinghua Zhao1, Ruili Huang1
1National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD.
Abstract:
The farnesoid X receptor (FXR) regulates the homeostasis of bile acids, lipids, and glucose. Because endogenous chemicals bind and activate FXR, it is important to examine which xenobiotic compounds would disrupt normal receptor function. We used a cell-based human FXR β-lactamase (Bla) reporter gene assay to profile the Tox21 10K compound collection of environmental chemicals and drugs. Structure-activity relationships of FXR-active compounds revealed by this screening were then compared against the androgen receptor, estrogen receptor α, peroxisome proliferator-activated receptors δ and γ, and the vitamin D receptor. We identified several FXR-active structural classes including anthracyclines, benzimidazoles, dihydropyridines, pyrethroids, retinoic acids, and vinca alkaloids. Microtubule inhibitors potently decreased FXR reporter gene activity. Pyrethroids specifically antagonized FXR transactivation. Anthracyclines affected reporter activity in all tested assays, suggesting non-specific activity. These results provide important information to prioritize chemicals for further investigation, and suggest possible modes of action of compounds in FXR signaling.
Insights
Environmental chemicals and drugs were screened for their effects on the farnesoid X receptor (FXR), a key regulator of metabolic homeostasis. Several compound classes, including pyrethroids and microtubule inhibitors, were found to disrupt FXR activity, offering insights into potential toxicological mechanisms.
Area of Science:
- Endocrinology and Toxicology
- Molecular Biology
- Pharmacology
Background:
- The farnesoid X receptor (FXR) is a crucial nuclear receptor regulating bile acid, lipid, and glucose metabolism.
- Understanding how xenobiotics interact with FXR is vital for assessing potential disruptions to metabolic homeostasis.
Purpose of the Study:
- To screen a large collection of environmental chemicals and drugs for activity against the human FXR.
- To identify structural classes of compounds that modulate FXR function and compare their activity profiles with other nuclear receptors.
Main Methods:
- A cell-based human FXR β-lactamase (Bla) reporter gene assay was employed to screen the Tox21 10K compound library.
- Structure-activity relationships were analyzed, and FXR-active compounds were compared against assays for androgen receptor, estrogen receptor α, PPARs, and VDR.
Main Results:
- Several FXR-active structural classes were identified, including anthracyclines, benzimidazoles, dihydropyridines, pyrethroids, retinoic acids, and vinca alkaloids.
- Microtubule inhibitors significantly reduced FXR reporter gene activity, while pyrethroids acted as specific FXR antagonists.
- Anthracyclines exhibited non-specific activity across multiple tested assays.
Conclusions:
- This screening provides a prioritized list of chemicals for further toxicological investigation.
- The identified compounds and their structure-activity relationships offer insights into potential mechanisms of FXR signaling disruption by xenobiotics.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Quantitative Aspects of Drug-Receptor Interaction
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Drug Metabolism: Overview

